|
Name |
14-Hydroxydihydromelleolide
|
| Molecular Formula | C23H30O7 | |
| IUPAC Name* |
[(2R,2aS,4aS,6S,7bR)-2a-hydroxy-3,6-bis(hydroxymethyl)-6,7b-dimethyl-1,2,4a,5,7,7a-hexahydrocyclobuta[e]inden-2-yl] 2,4-dihydroxy-6-methylbenzoate
|
|
| SMILES |
CC1=CC(=CC(=C1C(=O)O[C@@H]2C[C@]3([C@@]2(C(=C[C@H]4C3C[C@@](C4)(C)CO)CO)O)C)O)O
|
|
| InChI |
InChI=1S/C23H30O7/c1-12-4-15(26)6-17(27)19(12)20(28)30-18-9-22(3)16-8-21(2,11-25)7-13(16)5-14(10-24)23(18,22)29/h4-6,13,16,18,24-27,29H,7-11H2,1-3H3/t13-,16?,18-,21+,22-,23+/m1/s1
|
|
| InChIKey |
HDGURVCSOJDUHT-GJQGFOMNSA-N
|
|
| Synonyms |
14-Hydroxydihydromelleolide
|
|
| CAS | NA | |
| PubChem CID | 102068113 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 418.5 | ALogp: | 2.4 |
| HBD: | 5 | HBA: | 7 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 127.0 | Aromatic Rings: | 4 |
| Heavy Atoms: | 30 | QED Weighted: | 0.376 |
| Caco-2 Permeability: | -5.6 | MDCK Permeability: | 0.00000397 |
| Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.124 |
| Human Intestinal Absorption (HIA): | 0.061 | 20% Bioavailability (F20%): | 0.959 |
| 30% Bioavailability (F30%): | 0.022 |
| Blood-Brain-Barrier Penetration (BBB): | 0.131 | Plasma Protein Binding (PPB): | 85.58% |
| Volume Distribution (VD): | 0.832 | Fu: | 14.36% |
| CYP1A2-inhibitor: | 0.57 | CYP1A2-substrate: | 0.374 |
| CYP2C19-inhibitor: | 0.065 | CYP2C19-substrate: | 0.355 |
| CYP2C9-inhibitor: | 0.253 | CYP2C9-substrate: | 0.136 |
| CYP2D6-inhibitor: | 0.172 | CYP2D6-substrate: | 0.087 |
| CYP3A4-inhibitor: | 0.899 | CYP3A4-substrate: | 0.23 |
| Clearance (CL): | 6.801 | Half-life (T1/2): | 0.833 |
| hERG Blockers: | 0.034 | Human Hepatotoxicity (H-HT): | 0.337 |
| Drug-inuced Liver Injury (DILI): | 0.945 | AMES Toxicity: | 0.13 |
| Rat Oral Acute Toxicity: | 0.097 | Maximum Recommended Daily Dose: | 0.875 |
| Skin Sensitization: | 0.355 | Carcinogencity: | 0.685 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.132 |
| Respiratory Toxicity: | 0.18 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001937 | ![]() |
0.505 | D08PIQ | ![]() |
0.252 | ||
| ENC000887 | ![]() |
0.495 | D07DVK | ![]() |
0.248 | ||
| ENC003451 | ![]() |
0.434 | D03BLF | ![]() |
0.248 | ||
| ENC003450 | ![]() |
0.434 | D03IKT | ![]() |
0.248 | ||
| ENC002145 | ![]() |
0.418 | D0CW1P | ![]() |
0.248 | ||
| ENC003839 | ![]() |
0.414 | D0F1EX | ![]() |
0.248 | ||
| ENC003838 | ![]() |
0.414 | D0IT2G | ![]() |
0.248 | ||
| ENC003449 | ![]() |
0.414 | D0D1SG | ![]() |
0.246 | ||
| ENC002788 | ![]() |
0.405 | D0E9KA | ![]() |
0.244 | ||
| ENC002211 | ![]() |
0.404 | D0I5DS | ![]() |
0.242 | ||